Global Muscle Relaxant Drugs Market Size & Outlook
Global muscle relaxant drugs market, 2018-2030 (US$M)
Related Markets
Global muscle relaxant drugs market highlights
- The global muscle relaxant drugs market generated a revenue of USD 3,749.2 million in 2022 and is expected to reach USD 5,284.9 million by 2030.
- The market is expected to grow at a CAGR (2023 - 2030) of 4.4% by 2030.
- In terms of segment, skeletal muscle relaxant drugs accounted for a revenue of USD 1,370.1 million in 2022.
- Neuromuscular Blocking Agents is the most lucrative product segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2022.
- Country-wise, UK is expected to register the highest CAGR from 2023 to 2030.
Global data book summary
| Market revenue in 2022 | USD 3,749.2 million |
| Market revenue in 2030 | USD 5,284.9 million |
| Growth rate | 4.4% (CAGR from 2022 to 2030) |
| Largest segment | Skeletal muscle relaxant drugs |
| Fastest growing segment | Neuromuscular Blocking Agents |
| Historical data covered | 2018 - 2021 |
| Base year for estimation | 2022 |
| Forecast period covered | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Skeletal Muscle Relaxant Drugs, Facial Muscle Relaxant Drugs, Neuromuscular Blocking Agents |
Other key industry trends
- In terms of revenue, the North America accounted for 37.6% of the global muscle relaxant drugs market in 2022.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
- By country, UK is the fastest growing regional market and is projected to reach USD 380.8 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Muscle Relaxant Drugs Market Scope
Muscle Relaxant Drugs Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| SteriMax | View profile | 101-250 | Oakville, Ontario, Canada, North America | https://www.sterimaxinc.com |
| Vertical Pharmaceuticals | View profile | 251-500 | Bridgewater, New Jersey, United States, North America | http://www.verticalpharma.com |
| Par Pharmaceutical | View profile | 501-1000 | Mumbai, Maharashtra, India, Asia | https://parsterileproducts.com |
| Amneal Pharmaceuticals | View profile | 5001-10000 | Bridgewater, New Jersey, United States, North America | http://amneal.com/ |
| Ipsen SA | View profile | 5325 | 65 Quai Georges Gorse, Billancourt Cedex, Boulogne, France, 92100 | https://www.ipsen.com |
| Endo Pharmaceuticals | View profile | 1001-5000 | Ballsbridge, Dublin, Ireland, Europe | http://www.endo.com |
| Eisai Co Ltd | View profile | 11076 | 4-6-10 Koishikawa, Bunkyo-ku, Tokyo, Japan, 112-8088 | http://www.eisai.co.jp |
| Merz Pharma | View profile | 5001-10000 | Deutsch, Sachsen, Germany, Europe | http://www.merz.com |
| Mallinckrodt PLC Ordinary Shares - New | View profile | 2700 | College Business and Technology Park, Cruiserath, Blanchardstown, Dublin, Ireland, 15 | https://www.mallinckrodt.com |
| Teva Pharmaceutical Industries Ltd | View profile | 37851 | 124 Dvora HaNevi’a Street, Tel Aviv, Israel, 6944020 | https://www.tevapharm.com |
Global muscle relaxant drugs market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to muscle relaxant drugs market will help companies and investors design strategic landscapes.
Skeletal muscle relaxant drugs was the largest segment with a revenue share of 36.54% in 2022. Horizon Databook has segmented the Global muscle relaxant drugs market based on skeletal muscle relaxant drugs, facial muscle relaxant drugs, neuromuscular blocking agents covering the revenue growth of each sub-segment from 2018 to 2030.
- Global Muscle Relaxant Drugs Product Outlook (Revenue, USD Million, 2018-2030)
- Neuromuscular Blocking Agents
- Skeletal Muscle Relaxant Drugs
- Facial Muscle Relaxant Drugs
- Global Muscle Relaxant Drugs Route of Administration Outlook (Revenue, USD Million, 2018-2030)
- Oral
- Injectable
- Global Muscle Relaxant Drugs Distribution Channel Outlook (Revenue, USD Million, 2018-2030)
- Retail Pharmacy
- Online Pharmacy
- Hospital Pharmacy
Reasons to subscribe to Global muscle relaxant drugs market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global muscle relaxant drugs market databook
-
Our clientele includes a mix of muscle relaxant drugs market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global muscle relaxant drugs market , including forecasts for subscribers. This global databook contains high-level insights into Global muscle relaxant drugs market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Global muscle relaxant drugs market report size, by regions, 2018-2030 (US$M)
Top 10 countries: Muscle relaxant drugs market report size, 2022 (US$M)
Global muscle relaxant drugs market report share, by route of administration, 2022 & 2030 (%, US$M)
Muscle relaxant drugs market: Opportunity assessment by country
Global muscle relaxant drugs market, by region, 2022 (US$M)
Related industry reports
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
